PipelinePharma Logo
PipelinePharma Logo
Marketplace
Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Lurasidone manufacturers

Filters

Filters

Filters , active

Country of origin : China

Clear all

None products found

lurasidone

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Manufacturer usually replies in 5 days

lurasidone

Tablets 40 mg, 80 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Manufacturer usually replies in 5 days

lurasidone

Tablets 40 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
EU GMP
Comments
Ref. Latuda. Dossier status: Pilot BE completed. Validation stage
Manufacturer #10844
A pharmaceutical manufacturer operating as an end-to-end CDMO/CMO partner for pharmaceutical products, with vertically integrated capabilities spanning active pharmaceutical ingredients, intermediates, and finished oral solid dosage forms such as tablets and capsules. The company highlights multiple cGMP-inspected manufacturing sites supporting both API and formulation supply, alongside strong in-house development and analytical support for scale-up and commercial production. Its quality system is described as fully GMP-driven across operations, with APIs having undergone EU-GMP inspection/certification and oral solid pharmaceutical products produced under Chinese GMP requirements, reinforced by a mature EHS and compliance culture to ensure reliable global supply.

Manufacturer usually replies in 72 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Lurasidone is an antipsychotic medication used to treat schizophrenia and bipolar disorder. Suppliers of lurasidone market it in the form of oral tablets. Alternatives to it are other antipsychotic medications such as perospirone, risperidone, paliperidone, and iloperidone. The developer and earliest manufacturer of lurasidone medications was Sunovion Pharmaceuticals, which first introduced the drug into the market in 2010 under the trade name Latuda. It has since become approved in Canada and across the EU and has seen widespread use, with over 2 million prescriptions for it being registered annually in the U.S. alone. Lurasidone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified lurasidone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.